Daily low-dose prednisolone to prevent relapse of steroid-sensitive nephrotic syndrome in children with an upper respiratory tract infection: PREDNOS2 RCT
Christian MT, Webb NJA, Woolley RL, Afentou N, Mehta S, Frew E, Brettell EA, Khan AR, Milford DV, Bockenhauer D, Saleem MA, Hall AS, Koziell A, Maxwell H, Hegde S, Finlay ER, Gilbert RD, Jones C, McKeever K, Cook W, Ives N
            Record ID 32013001074
            English
                        
                Original Title:
                Short course daily prednisolone therapy at the time of upper respiratory tract infection in children with relapsing steroid sensitive nephrotic syndrome; the PREDNOS 2 study
            
                                    
                Authors' objectives:
                Most children with steroid-sensitive nephrotic syndrome have relapses that are triggered by upper respiratory tract infections. Four small trials, mostly in children already taking maintenance corticosteroid in countries of different upper respiratory tract infection epidemiology, showed that giving daily low-dose prednisone/prednisolone for 5–7 days during an upper respiratory tract infection reduces the risk of relapse.
To determine if these findings were replicated in a large UK population of children with relapsing steroid-sensitive nephrotic syndrome on different background medication or none.
            
                                                            
            Details
                        
                Project Status:
                Completed
            
                                    
                URL for project:
                https://www.journalslibrary.nihr.ac.uk/programmes/hta/11129261/#/
            
                                                
                Year Published:
                2022
            
                                    
                URL for published report:
                https://www.journalslibrary.nihr.ac.uk/hta/WTFC5658
            
                                    
                Requestor:
                NIHR Health Technology Assessment programme
            
                                                
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Full HTA
            
                                    
                Country:
                England, United Kingdom
            
                                                            
            
                        MeSH Terms
            - Nephrotic Syndrome
 - Prednisolone
 - Child
 - Respiratory Tract Infections
 - Child, Preschool
 
Contact
                        
                Organisation Name:
                NIHR Health Technology Assessment programme
            
            
                        
                Contact Address:
                NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
            
                                    
                Contact Name:
                journals.library@nihr.ac.uk
            
                                    
                Contact Email:
                journals.library@nihr.ac.uk
            
                                
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.